サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1218915

米国のD2C (消費者直接取引) 遺伝子検査市場 (2023年～2032年)：市場規模 (検査・技術・流通チャネル別)・用途の潜在性・競合市場シェア・予測

U.S. Direct-to-Consumer Genetic Testing Market Size By Test, By Technology, By Distribution Channel, Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2023 - 2032
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 60 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
米国のD2C (消費者直接取引) 遺伝子検査市場 (2023年～2032年)：市場規模 (検査・技術・流通チャネル別)・用途の潜在性・競合市場シェア・予測
出版日: 2023年01月19日
発行: Global Market Insights Inc.
ページ情報: 英文 60 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国のD2C (消費者直接取引) 遺伝子検査の市場は、2023年から2032年にかけて大幅な成長を示すと予想されています。

遺伝性疾患に関する認知度の向上、個人に合わせた健康情報の提供、健康に対する積極性の向上、安価であることなど、DTC遺伝子検査に関連するいくつかの利点が、今後数年間でその需要をさらに刺激すると予想されています。

技術別で見ると、標的分析の部門が2022年に5億4,200万米ドル超の規模を示しています。また、販売チャネル別では、2023年から2032年にかけてOTCの部門が大きな利益を上げると予想されています。

当レポートでは、米国のD2C (消費者直接取引) 遺伝子検査の市場を調査し、市場概要、市場成長への各種影響因子の分析、法規制・償還環境、技術情勢、市場規模の推移・予測、各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 米国のD2C (消費者直接取引) 遺伝子検査産業の考察

  • 産業情勢
  • 産業への影響要因
    • 促進要因
    • 潜在的リスク＆課題
  • 成長性分析
  • COVID-19影響分析
  • 技術情勢
  • 今後の市場動向
  • 規制状況
  • バリューチェーン分析
  • データのプライバシーに関する懸念
  • 米国DTC遺伝子検査- 価格分析
  • 償還シナリオ
  • ポーターの分析
  • PESTEL分析

第4章 競合情勢

  • 企業マトリックス分析
  • 企業の市場シェア分析
  • 戦略ダッシュボード

第5章 米国のD2C (消費者直接取引) 遺伝子検査市場：検査タイプ別

  • 主要動向
  • キャリア検査
  • 予測検査
  • 祖先・血縁検査
  • ニュートリゲノミクス検査
  • スキンケア検査
  • その他

第6章 米国のD2C (消費者直接取引) 遺伝子検査市場：技術別

  • 主要動向
  • 標的分析
  • 一塩基多型 (SNP) チップ
  • 全ゲノムシーケンシング (WGS)

第7章 米国のD2C (消費者直接取引) 遺伝子検査市場：流通チャネル別

  • 主要動向
  • オンラインプラットフォーム
  • OTC

第8章 企業プロファイル

  • 23andMe, Inc.
  • Ancestry
  • Counsyl
  • Easy DNA
  • HomeDNA
  • Family Tree DNA（Gene By Gene）
  • Full Genome Corporation Inc.
  • Helix OpCo LLC
  • Identigene, Inc.
  • Karmagenes SA
  • Living DNA Ltd.
  • MyHeritage Ltd.
  • Pathway genomics
  • Genesis Healthcare Co.
  • The SkinDNA Company Pty Ltd
  • Ambry Genetics
  • Blueprint Genetics Oy
  • DNA Genotek Inc.
  • Dante Lab
  • DNA Diagnostic Center
図表

Data Tables

  • TABLE 1. Product mapping
  • TABLE 2. Market revenue, by test type (2022)
  • TABLE 3. Market revenue, by technology (2022)
  • TABLE 4. Market share, by distribution channel (2022)
  • TABLE 5. U.S. direct-To-Consumer (DTC) genetic testing market, 2018 - 2024 (USD Million)
  • TABLE 6. U.S. direct-To-Consumer (DTC) genetic testing market, 2025 - 2032 (USD Million)
  • TABLE 7. U.S. direct-To-Consumer (DTC) genetic testing market, 2018 - 2024 (Units)
  • TABLE 8. U.S. direct-To-Consumer (DTC) genetic testing market, 2025 - 2032 (Units)
  • TABLE 9. U.S. direct-To-Consumer (DTC) genetic testing market, by test type, 2018 - 2024 (USD Million)
  • TABLE 10. U.S. direct-To-Consumer (DTC) genetic testing market, by test type, 2025 - 2032 (USD Million)
  • TABLE 11. U.S. direct-To-Consumer (DTC) genetic testing market, by test type, 2018 - 2024 (Units)
  • TABLE 12. U.S. direct-To-Consumer (DTC) genetic testing market, by test type, 2025 - 2032 (Units)
  • TABLE 13. U.S. direct-To-Consumer (DTC) genetic testing market, by technology, 2018 - 2024 (USD Million)
  • TABLE 14. U.S. direct-To-Consumer (DTC) genetic testing market, by technology, 2025 - 2032 (USD Million)
  • TABLE 15. U.S. direct-To-Consumer (DTC) genetic testing market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 16. U.S. direct-To-Consumer (DTC) genetic testing market, by distribution channel, 2025 - 2032 (USD Million)
  • TABLE 17. Industry impact forces
  • TABLE 18. Carrier testing market, 2018 - 2024 (USD Million)
  • TABLE 19. Carrier testing market, 2025 - 2032 (USD Million)
  • TABLE 20. Carrier testing market, 2018 - 2024 (Units)
  • TABLE 21. Carrier testing market, 2025 - 2032 (Units)
  • TABLE 22. Predictive testing market, 2018 - 2024 (USD Million)
  • TABLE 23. Predictive testing market, 2025 - 2032 (USD Million)
  • TABLE 24. Predictive testing market, 2018 - 2024 (Units)
  • TABLE 25. Predictive testing market, 2025 - 2032 (Units)
  • TABLE 26. Ancestry & relationship testing market, 2018 - 2024 (USD Million)
  • TABLE 27. Ancestry & relationship testing market, 2025 - 2032 (USD Million)
  • TABLE 28. Ancestry & relationship testing market, 2018 - 2024 (Units)
  • TABLE 29. Ancestry & relationship testing market, 2025 - 2032 (Units)
  • TABLE 30. Nutrigenomics testing market, 2018 - 2024 (USD Million)
  • TABLE 31. Nutrigenomics testing market, 2025 - 2032 (USD Million)
  • TABLE 32. Nutrigenomics testing market, 2018 - 2024 (Units)
  • TABLE 33. Nutrigenomics testing market, 2025 - 2032 (Units)
  • TABLE 34. Skincare testing market, 2018 - 2024 (USD Million)
  • TABLE 35. Skincare testing market, 2025 - 2032 (USD Million)
  • TABLE 36. Skincare testing market, 2018 - 2024 (Units)
  • TABLE 37. Skincare testing market, 2025 - 2032 (Units)
  • TABLE 38. Others market, 2018 - 2024 (USD Million)
  • TABLE 39. Others market, 2025 - 2032 (USD Million)
  • TABLE 40. Others market, 2018 - 2024 (Units)
  • TABLE 41. Others market, 2025 - 2032 (Units)
  • TABLE 42. Targeted analysis market, 2018 - 2024 (USD Million)
  • TABLE 43. Targeted analysis market, 2025 - 2032 (USD Million)
  • TABLE 44. Single nucleotide polymorphism (SNP) chips market, 2018 - 2024 (USD Million)
  • TABLE 45. Single nucleotide polymorphism (SNP) chips market, 2025 - 2032 (USD Million)
  • TABLE 46. Whole genome sequencing [WGS] market, 2018 - 2024 (USD Million)
  • TABLE 47. Whole genome sequencing [WGS] market, 2025 - 2032 (USD Million)
  • TABLE 48. Online platforms market, 2018 - 2024 (USD Million)
  • TABLE 49. Online platforms market, 2025 - 2032 (USD Million)
  • TABLE 50. Over-the-counter market, 2018 - 2024 (USD Million)
  • TABLE 51. Over-the-counter market, 2025 - 2032 (USD Million)

Charts & Figures

  • FIG. 1 GMI report coverage: Critical research elements
  • FIG. 2 Industry segmentation
  • FIG. 3 Top-down approach
  • FIG. 4 Market estimation and forecast methodology
  • FIG. 5 Market forecasting methodology
  • FIG. 6 Breakdown of primary participants
  • FIG. 7 Industry landscape, 2018 - 2032 (USD Million)
  • FIG. 8 Growth potential analysis, by test type
  • FIG. 9 Growth potential analysis, by technology
  • FIG. 10 Growth potential analysis, by distribution channel
  • FIG. 11 Porter's analysis
  • FIG. 12 PESTEL analysis
  • FIG. 13 Company matrix analysis, 2021
  • FIG. 14 Company market share analysis, 2021
  • FIG. 15 Strategy dashboard, 2021
目次
Product Code: 4368

U.S. Direct-to-Consumer (DTC) Genetic Testing Market is expected to demonstrate substantial growth from 2023 to 2032. DTC genetic testing offers people access to genetic information without involving a healthcare provider or health insurance company. Besides, several benefits associated with DTC genetics, such as promoting awareness regarding genetic diseases, offering personalized health information, making people more proactive about their health, and being less expensive, are anticipated to further stimulate its demand in the coming years.

In addition, the U.S. DTC genetic testing market is anticipated to increase owing to the growing prevalence of rare genetic diseases. Moreover, technological innovations in the healthcare industry are also anticipated to foster the demand for DTC genetic testing. The constantly growing investments made in the healthcare infrastructure in the U.S. and the high accuracy & efficiency possessed by DTC genetic tests will surge the demand and prove beneficial for industry growth over the foreseeable period.

Conglomerates working in the U.S. direct-to-consumer (DTC) industry are persistently taking strategic initiatives to gain a competitive advantage in the overall market. To cite an instance, in January 2021, myDNA merged with Gene by Gene and FamilyTreeDNA. The two businesses have amalgamated to become one of the leading global experts in genealogy, pharmacogenomic and nutrigenomic services. Besides, the merger is grounded on several shared beliefs about the tremendous potential of genetic information.

Overall, the U.S. direct-to-consumer (DTC) genetic testing industry is segmented in terms of test type, technology, and distribution channel.

Based on test type, the carrier testing segment is anticipated to experience robust growth through 2032, primarily due to the increasing cases of rare genetic diseases. Carrier testing determines if an individual carries a genetic variation (allele) related to a specific disease or trait. The landscape of rare diseases is constantly changing as new rare conditions or diseases are regularly identified and reported, which is anticipated to help the segment grow in the coming years.

By technology, the targeted analysis segment was valued at over USD 542 million in 2022. The targeted analysis determines the defects in genes that cause disorders. Besides, targeted genotyping empowers researchers to focus more on specific regions of interest, generates a smaller and more manageable dataset, reduces data analysis burden, and offers a cost-efficient solution with decreased turnaround time compared to broader approaches.

On the basis of distribution channel, over-the-counter segment is anticipated to amass considerable gains during 2023-2032. DTC genetic testing devices and drugs available over the counter enable people to self-treat without the need for prescription, while saving health systems valuable resources and consumers' money and time.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Industry coverage
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact analysis at country level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

    • 2.1.1 Business trends

Chapter 3 US Direct-To-Consumer (DTC) Genetic Testing Industry Insights

  • 3.1 Industry landscape, 2018 - 2032
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising public awareness regarding DTC genetic tests
      • 3.2.1.2 Increasing demand for personalized DTC genetic services
      • 3.2.1.3 Rising incidences of genetic disorders
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Defects in the DTC testing
      • 3.2.2.2 Data privacy concerns associated with DTC genetic testing
  • 3.3 Growth potential analysis
    • 3.3.1 By test type
    • 3.3.2 By technology
    • 3.3.3 By distribution channel
  • 3.4 COVID-19 impact analysis
  • 3.5 Technology landscape
  • 3.6 Future market trends
  • 3.7 Regulatory landscape
  • 3.8 Value chain analysis
  • 3.9 Data privacy concerns
  • 3.10 U.S. DTC genetic testing - pricing analysis, 2021
  • 3.11 Reimbursement scenario
  • 3.12 Porter's analysis
  • 3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2021
  • 4.3 Company market share analysis, 2021
  • 4.4 Strategy dashboard, 2021

Chapter 5 US Direct-To-Consumer (DTC) Genetic Testing Market, By Test Type

  • 5.1 Key segment trends
  • 5.2 Carrier testing
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
  • 5.3 Predictive testing
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
  • 5.4 Ancestry & Relationship Testing
    • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
  • 5.5 Nutrigenomics Testing
    • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
  • 5.6 Skincare Testing
    • 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
  • 5.7 Others
    • 5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)

Chapter 6 US Direct-To-Consumer (DTC) Genetic Testing Market, By Technology

  • 6.1 Key segment trends
  • 6.2 Targeted analysis
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Single nucleotide polymorphism (SNP) chips
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.4 Whole genome sequencing [WGS]
    • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 US Direct-To-Consumer (DTC) Genetic Testing Market, By Distribution Channel

  • 7.1 Key segment trends
  • 7.2 Online platforms
    • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.3 Over-the-Counter
    • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Company Profiles

  • 8.1 23andMe, Inc.
  • 8.2 Ancestry
  • 8.3 Counsyl
  • 8.4 Easy DNA
  • 8.5 HomeDNA
  • 8.6 Family Tree DNA (Gene By Gene)
  • 8.7 Full Genome Corporation Inc.
  • 8.8 Helix OpCo LLC
  • 8.9 Identigene, Inc.
  • 8.10 Karmagenes SA
  • 8.11 Living DNA Ltd.
  • 8.12 MyHeritage Ltd.
  • 8.13 Pathway genomics
  • 8.14 Genesis Healthcare Co.
  • 8.15 The SkinDNA Company Pty Ltd
  • 8.16 Ambry Genetics
  • 8.17 Blueprint Genetics Oy
  • 8.18 DNA Genotek Inc.
  • 8.19 Dante Lab
  • 8.20 DNA Diagnostic Center